Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
For monitoring effi cacy of sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy, data obtained from studies of children seemed inadequate.High prevalence of triple and quadruple mutants in the dihydropteroate synthase and dihydrofolate reductase genes of Plasmodium falciparum parasites contrasts with the effi cacy of sulfadoxine/pyrimethamine in reducing low birthweights and placental infection rates.In light of this discrepancy, emphasis on using molecular markers for monitoring effi cacy of intermittent preventive treatment dur-ing pregnancy appears questionable.The World Health Organization recently proposed conducting in vivo studies in pregnant women to evaluate molecular markers for detecting resistance precociously.Other possible alternative strategies are considered.M alaria during pregnancy is a major cause of anemia and maternal death and one of the main causes of low birthweight (1,2).Consequently, the World Health Organization (WHO) recommends protection for women during pregnancy.Until recently, prevention consisted of weekly chemoprophylaxis with either chloroquine or sulfadoxine/ pyrimethamine.Because of poor patient compliance with prophylaxis and increasing resistance of parasite strains to chloroquine, administration of intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine/pyrimethamine Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432
Brooks, D. R., Wang, P., Read, M., Watkins, W. M., Sims, P. F. G., & Hyde, J. E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00397.x · Cited by 369 · cited 1×
“Similarly, resistance to sulfadoxine is associated with 3 mutations in dhps: Ala437Gly, Ser436Phe, and Lys540Glu (19,20).”
BackgroundO. ter Kuile, F., van Eijk, A. M., & Filler, S. J. (2007) · JAMA · doi:10.1001/jama.297.23.2603 · Cited by 355
Peters, P. J., Thigpen, M. C., Parise, M. E., & Newman, R. D. (2007) · Drug Safety · doi:10.2165/00002018-200730060-00003 · Cited by 174 · cited 1×
“Conversely, treatment with sulfadoxine/ pyrimethamine for a woman who has recently received (or will soon receive) a regimen of sulfadoxine/pyrimethamine as part of IPTp may increase the risk for drug hepato-toxicity and severe cutaneous side effects (37).”
BackgroundBriand, V., Bottero, J., Noël, H., Masse, V., Cordel, H., Guerra, J., Kossou, H., Fayomi, B., Ayemonna, P., Fievet, N., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605474 · Cited by 98
Self-citationFaucher, J., Aubouy, A., Adeothy, A., Cottrell, G., Doritchamou, J., Gourmel, B., Houzé, P., Kossou, H., Amedome, H., Massougbodji, A., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/599378 · Cited by 61 · cited 1×
“In southern Benin, where the in vivo resistance rate to sulfadoxine/pyrimethamine reached 72% in children <5 years of age at day 28 (9), IPTp with sulfadoxine/pyrimethamine was still able to reduce the rate of low birthweight by 40% and the proportion of placental infection by 75% compared with the effi cacy of chloro…”
ResultSelf-citationMutabingwa, T. K., Muze, K., Ord, R., Briceño, M., Greenwood, B. M., Drakeley, C., & Whitty, C. J. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005138 · Cited by 53 · cited 1×
“In Tanzania, 28 days after treatment with sulfadoxine/ pyrimethamine, the rate of treatment failure was 16% in pregnant women and 80% in children <5 years of age 2 years earlier (14).”
BackgroundBriand, V., Denoeud, L., Massougbodji, A., & Cot, M. (2008) · The Journal of Infectious Diseases · doi:10.1086/590114 · Cited by 34
Self-citation
Cited by
Bertin, G., Briand, V., Bonaventure, D., Carrieu, A., Massougbodji, A., Cot, M., & Deloron, P. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-196 · Cited by 37
Self-citationKayiba, N. K., Yobi, D. M., Tchakounang, V. R. K., Mvumbi, D. M., Kabututu, P. Z., Devleesschauwer, B., Mukomena, E. S., DeMol, P., Hayette, M.-P., Mvumbi, G. L., et al. (2021) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2021.105009 · Cited by 22
Manore, C. A., Teboh-Ewungkem, M. I., Prosper, O., Peace, A., Gurski, K., & Feng, Z. (2019) · Bulletin of Mathematical Biology · doi:10.1007/s11538-018-0524-1 · Cited by 18
“IPT has been shown to be efficacious in reducing malaria incidence and burden in pregnant women, infants, and children (Deloron et al. 2010; Konaté et al. 2011; ter Kuile et al. 2007; Matangila et al. 2015).”
BackgroundOgieuhi, I. J., Ajekiigbe, V. O., Kolo-Manma, K., Akingbola, A., Odeniyi, T. A., Soyemi, T. S., Ayomide, J. H., Thiyagarajan, B., & Awolola, B. D. (2024) · Discover Public Health · doi:10.1186/s12982-024-00284-w · Cited by 13
Malaria – Current Treatment Options
Virginia, D. M., Shegokar, R., & Pathak, Y. (2023) · Malarial Drug Delivery Systems · doi:10.1007/978-3-031-15848-3_4 · Cited by 1
Metadata
- Authors
- Deloron, P., Bertin, G., Briand, V., Massougbodji, A., & Cot, M.
- Venue
- Emerging Infectious Diseases
- Published
- 2010-11
- Volume
- 16
- Issue
- 11
- Pages
- 1666-1670
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W1988942657
- Cited by
- 29
- References
- 8
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.